NCT07449624

Brief Summary

Pleural effusion is a common clinical condition characterized by the accumulation of excess fluid within the pleural space due to disruption of normal pleural fluid dynamics. The etiology is diverse and includes systemic conditions such as congestive heart failure, liver cirrhosis, and renal disease, as well as localized pleural pathologies including infection, malignancy, and inflammatory disorders. Accurate classification of pleural effusion into transudative and exudative types, primarily using biochemical parameters such as Light's criteria, remains the cornerstone of diagnostic evaluation and guides subsequent clinical management.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 26, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 4, 2026

Completed
Last Updated

March 4, 2026

Status Verified

March 1, 2026

Enrollment Period

5.9 years

First QC Date

February 26, 2026

Last Update Submit

March 3, 2026

Conditions

Keywords

Pleural effusionThoracoscopyPleural biopsy

Outcome Measures

Primary Outcomes (1)

  • Distribution of underlying etiologies of pleural effusion among patients treated at Mansoura University Hospitals

    Number of patients diagnosed with each underlying cause of pleural effusion (e.g., malignancy, tuberculosis, parapneumonic effusion, heart failure, liver cirrhosis, renal failure, and others) based on clinical evaluation, radiological findings, and pleural fluid analysis.

    5 years

Study Arms (1)

Pleural effusion

evaluate the patterns, clinical features, pleural fluid characteristics, and etiologies of Pleural effusion among patients treated at Mansoura University, providing a comprehensive overview of the disease in this region.

Diagnostic Test: Pleural effusion pathology

Interventions

describe the demographic and clinical characteristics of patients presenting with pleural effusion. To classify pleural effusions into transudates and exudates using Light's criteria. To determine the most common etiologies of pleural effusion in Mansoura University. To evaluate the relationship between clinical presentation, radiological findings,

Pleural effusion

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients (\>18 years) diagnosed with pleural effusion between January 2020 and December 2025.

You may qualify if:

  • All patients with documented pleural effusion confirmed by chest imaging (X-ray, ultrasound, or CT).
  • Patients with complete clinical, laboratory, and radiological records.

You may not qualify if:

  • Patients with incomplete medical records.
  • Pediatric patients (\<18 years).
  • Patients with post-surgical pleural collections unrelated to systemic or pathological causes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mohamed AbdElmoniem

Al Mansurah, 35516, Egypt

Location

MeSH Terms

Conditions

Mesothelioma, MalignantPleural Effusion

Condition Hierarchy (Ancestors)

MesotheliomaAdenomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsNeoplasms, MesothelialLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SitePleural NeoplasmsLung DiseasesRespiratory Tract DiseasesPleural Diseases

Study Officials

  • Mohamed AbdElmoniem

    Lecturer of chest medicine faculty of medicine Mansoura university

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer faculty of medicine

Study Record Dates

First Submitted

February 26, 2026

First Posted

March 4, 2026

Study Start

January 1, 2020

Primary Completion

December 1, 2025

Study Completion

January 1, 2026

Last Updated

March 4, 2026

Record last verified: 2026-03

Locations